Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Refine by:

Advanced search

Results 1 - 10 of 38
Order by: Results/page:
12 3 4 > 
Nanomaterial risk profiling puts safety first
With uncertainty around the risks of nanomaterials hampering the EU’s innovative potential, researchers are working on a safety concept to better monitor this emerging technology.
Programme: H2020-EU.2.1.2.
Record Number: 128637
Last updated on: 2017-10-18
Available languages: DE, EN, ES, FR, IT, PL
Profilowanie ryzyka związanego z nanomateriałami – bezpieczeństwo przede wszystkim
W świetle niepewności co do zagrożeń stwarzanych przez nanomateriały, która tłumi innowacyjny potencjał UE, naukowcy podjęli prace nad koncepcją bezpieczeństwa, aby lepiej monitorować rozwój tej powstającej technologii.
Programme: H2020-EU.2.1.2.
Record Number: 128637
Last updated on: 2017-10-18
Available languages: DE, EN, ES, FR, IT, PL
La sécurité avant tout, grâce à la définition du profil de risque des nanomatériaux
Face aux craintes que les incertitudes concernant les risques liés aux nanomatériaux ne nuisent à l'innovation européenne, des chercheurs travaillent à un concept de sécurité permettant de mieux contrôler cette nouvelle technologie.
Programme: H2020-EU.2.1.2.
Record Number: 128637
Last updated on: 2017-10-18
Available languages: DE, EN, ES, FR, IT, PL
Priorizar la seguridad en la caracterización de riesgos de los nanomateriales
En un momento de incertidumbre con respecto a los riesgos de los nanomateriales —una cuestión que limita el potencial para la innovación de la Unión Europea—, un equipo de investigadores está trabajando en un concepto de seguridad destinado a mejorar las labores de control rel...
Programme: H2020-EU.2.1.2.
Record Number: 128637
Last updated on: 2017-10-18
Available languages: DE, EN, ES, FR, IT, PL
L’analisi del rischio dei nanomateriali mette la sicurezza al primo posto
L’incertezza riguardo i rischi dei nanomateriali ostacola il potenziale innovativo dell’UE, per questo i ricercatori stanno lavorando a un concetto di sicurezza per monitorare meglio questa tecnologia emergente.
Programme: H2020-EU.2.1.2.
Record Number: 128637
Last updated on: 2017-10-18
Available languages: DE, EN, ES, FR, IT, PL
Sicherheit geht vor: Risikobewertung bei Nanomaterialien
Die Unsicherheiten hinsichtlich der mit Nanomaterialien verbundenen Risiken behindern das Innovationspotenzial der EU. Daher arbeiten Forscher nun an einem Sicherheitskonzept, mit dem diese neu aufkommende Technologie besser beobachten werden kann.
Programme: H2020-EU.2.1.2.
Record Number: 128637
Last updated on: 2017-10-18
Available languages: DE, EN, ES, FR, IT, PL
Nanomedicine Award 2017: deadline for applications extended till 1st October 2017!
The European Technology Platform for Nanomedicine (ETPN) and the EU-funded project ENATRANS, announce the launching of the 3rd edition of the Nanomedicine Award, which aim to promote and reward two excellent innovative nanomedicine-based solutions that could bring significant ...
Programme: H2020-EU.2.1.2.
Record Number: 140455
Last updated on: 2017-07-24
6th Round of applications for the NanomedTAB is open
The Nanomedicine Translation Advisory Board (nanomedTAB) offers since 2015 a free-of-charge mentoring program to assess, advise and accelerate promising nanomedicine projects to the market, based on a team of top skills industry experts with diverse and complementary experienc...
Programme: H2020-EU.2.1.2.
Record Number: 141499
Last updated on: 2017-07-24
Nanomedicine Translation around the globe - How to proper address regulatory processes for nanomedicines in different countries.
ENATRANS, the pathfinder for Nanobiomedical Translation, extends its compendium for nanomedicine entrepreneurs, SMEs and researchers with synopses of regulation processes in countries of major interest. Therefore packages with basic information on regulatory processes for USA,...
Programme: H2020-EU.2.1.2.
Record Number: 141416
Last updated on: 2017-06-20
Wytwarzanie nanoleków jutra
Finansowana ze środków UE terapia na bazie RNA obiera za cel przyczyny chorób neurodegeneracyjnych, a nie tylko ich objawy.
Programme: H2020-EU.2.1.2.
Record Number: 128346
Last updated on: 2017-05-31
Available languages: DE, EN, ES, FR, IT, PL
12 3 4 > 
List retrieved on: 2017-12-15
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top